Download PDF
Thromb Haemost 1980; 43(02): 090-094
DOI: 10.1055/s-0038-1650024
Original Article
Schattauer GmbH Stuttgart

Clinical Trials in the Secondary Prevention of Myocardial Infarction and Stroke[*]

P Armitage
Department of Biomathematics, University of Oxford, U. K.
› Author Affiliations
Further Information

Publication History

Publication Date:
13 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Keywords

Clinical trials - Randomization - Prognostic factors - Protocol departures - Factorial designs

* Plenary Lecture delivered to the VIIth International Congress on Thrombosis and Haemostasis, Queen Elizabeth Hall, London, 17th July 1979


 

  • References

  • 1 Burkhardt R, Kienle G. Controlled clinical trials and medical ethics. Lancet 1978; 2: 1356-1359
    PubMedSearch in Google Scholar
  • 2 Fincke M. Arzneimittelprüfung: Strafbare Versuchsmethoden. 1977 295: Heidelberg/Karlsruhe
    PubMedSearch in Google Scholar
  • 3 Gehan EA, Freireich EJ. Non-randomized controls in cancer clinical trials. N Engl J Med 1974; 290: 198-203
    CrossrefPubMedSearch in Google Scholar
  • 4 Pocock SJ. Randomised clinical trials (letter). Br Med J 1977; 1: 1661
    PubMedSearch in Google Scholar
  • 5 Peto R. Clinical trial methology. Biomedicine 1978; 28: 24-36
    PubMedSearch in Google Scholar
  • 6 Chalmers RC, Matta RJ, Smith H, Kunzler AM. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med 1977; 297: 1091-1096
    CrossrefPubMedSearch in Google Scholar
  • 7 Farewell VT, D'Angio GJ. A simulated study of historical controls using real data. (Submitted for publication, 1980.)
    PubMed
  • 8 Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. II. Analysis and examples. Br J Cancer 1976; 34: 585-612 and 1977; 35 1 39
    PubMedSearch in Google Scholar
  • 9 Pocock SJ, Armitage P, Galton DA G. The size of cancer clinical trials: an international survey. In Methods and Impact of Controlled Therapeutic Trials in Cancer Part I. UICC Technical Report Series 1978; 36: 5-32 Geneva, UICC
    PubMedSearch in Google Scholar
  • 10 Staquet M, Sylvester R, Machin D, van Glabbeke M, de Grauwe G, Wennerholm A, Tyrrell J, Renard J, de Pauw M, Eeckhoudt D, Tyrrell J, Tagnon HJ. The E.O.R.T.C. Data Center. Eur J Cancer 1977; 13: 1455-1459
    CrossrefPubMedSearch in Google Scholar
  • 11 Boissel J-P, Leizorovicz A, Sanchini B, Biron A. Quality control and clinical trials. In Proceedings of Working Conference on Evaluation of Efficacy of Medical Action. ed. Gremy F, Alperovitch A. 1980. North Holland:
    Search in Google Scholar
  • 12 Cox DR. Regression models and life-tables. J R Statist Soc Ser B 1972; 34: 187-202
    PubMedSearch in Google Scholar
  • 13 Gross AJ, Clark VA. Survival Distributions: Reliability Applications in the Biomedical Sciences. 1975. New York: Wiley:
    Search in Google Scholar
  • 14 Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-316
    CrossrefPubMedSearch in Google Scholar
  • 15 Anturane Reinfarction Trial Research Group Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. N Engl J Med 1978; 298: 289-295
    CrossrefPubMedSearch in Google Scholar
  • 16 Committee of Principal Investigators A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978; 40: 1069-1118
    CrossrefPubMedSearch in Google Scholar
  • 17 Canadian Cooperative Study Group A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-59
    CrossrefPubMedSearch in Google Scholar
  • 18 Walpole H. Letter to H. Mann, 28 Jan. 1754
    PubMedSearch in Google Scholar
  • 19 Lellouch J, Schwartz D. L'essai thérapeutique: éthique individuelle ou éthique collective?. Rev Inst Int Statist 1971; 39: 127-136
    PubMedSearch in Google Scholar
  • 20 Armitage P. Sequential Medical Trials. 1975. 2nd ed. Oxford: Blackwell:
    Search in Google Scholar
  • 21 Coronary Drug Project Research Group Aspirin in coronary heart disease. J Chronic Dis 1976; 29: 625-642
    CrossrefPubMedSearch in Google Scholar
  • 22 McPherson K. Statistics: the problem of examining accumulating data more than once. N Engl J Med 1974; 290: 501-502
    CrossrefPubMedSearch in Google Scholar
  • 23 Canner PL. Monitoring treatment differences in long-term clinical trials. Biometrics 1977; 33: 603-615
    CrossrefPubMedSearch in Google Scholar
  • 24 Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191-199
    CrossrefPubMedSearch in Google Scholar
  • 25 European Coronary Surgery Study Group Coronary-artery bypass surgery in stable angina pectoris: survival at two years. Lancet 1979; 1: 889-893
    PubMedSearch in Google Scholar
  • 26 Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis 1967; 20: 637-648
    CrossrefPubMedSearch in Google Scholar
  • 27 Gent M, Sackett DL. The qualification and disqualification of patients and events in long-term cardiovascular clinical trials. In: The Challenge of Clinical Trials in Thrombosis. ed Verstraate M, Vermylen J, Roberts H. 1979. pp. 123-134 Stuttgart: Schattauer Verlag:
    Search in Google Scholar
  • 28 Doll R. The concurrent assessment of several treatments. In Controlled Clinical Trials ed. CIOMS. 1960. pp. 94-99 Oxford: Blackwell:
    Search in Google Scholar
  • 29 Wilson C, Pollock MR, Harris AD. Diet in the treatment of infective hepatitis: therapeutic trials of cysteine and variation of fat content. Lancet 1946; 1: 881-883
    PubMedSearch in Google Scholar